US Patent 11365184 Antiproliferative compounds, and their pharmaceutical compositions and uses
Patent 11365184 was granted and assigned to Celgene on June, 2022 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
March 6, 2020
0
Date of Patent
June 21, 2022
0
Patent Applicant
Patent Application Number
16811414
0
Patent Inventor Names
John Sapienza
0
Joshua Hansen
0
Matthew D. Alexander
0
Matthew D. Correa
0
Raj Kumar Raheja
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 11365184 Antiproliferative compounds, and their pharmaceutical compositions and uses
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
